Grupos
GRUPOS DE INVESTIGACIÓN
País Vasco
Biosistemak - OSI Barrualde Galdakao
La fecha de inicio no puede ser superior a la fecha de fin.
A Circulating Signature of Tumour Hybrid Cells and Immune Checkpoints Predicts Metastatic Progression in Lung Cancer.
A Multidimensional Framework for Pharmaceutical Care to Enhance Medication Adherence and Patient Engagement: The CMO-MAPEX Model.
Assessment of the ADLIFE intervention as a digital solution for patients with advanced chronic diseases: a quasi-experimental trial.
Assessment of the risk of bacteremia in patients with hematologic malignancies in the emergency department: A comparative study between logistic regression and machine learning algorithms.
Best practices and challenges in executing large scale pilots for eHealth deployment and managing innovation: the GATEKEEPER experience.
Beyond text: Using network centralities and AI models to detect suicide risk on Reddit.
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.
Bringing the value equation into play in value-based healthcare.
Challenges of real data studies: Causality, intervention and reproducibility.
Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry.
Closing the implementation gap: the Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) as a proof of-concept for Europe's Safe Hearts Plan.
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.
Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?
Corrigendum to "Prevalence, risk factors, and prognosis of the need for physical and chemical restraint in older patients attending emergency departments. EDEN-50" [American Journal of Emergency Medicine 105C (2026) 79-87].
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?
Development and Validation of the Resilience in Eating Disorders Scale (RED-5).
Dynamic prediction of death risk given a renewal hospitalization process.
Epidemiology of multiple sclerosis in a healthcare area of the Basque Country, Northern Spain: A population-based study (2009-2023).
Esophageal, gastric and duodenal Crohn's disease in the biologic era: Results from a retrospective observational nationwide study of GETECCU.
Evaluation of the effectiveness of a screening program as compared to usual care in identifying patients with post-partum depression: a cohort study of 20,448 births in Bizkaia (Spain).
